Dr. St-Amand completed his doctoral studies at Laval University, and his postdoctoral studies at the University of British Columbia. In 1998, he optimized the SAGE method in his laboratory located in Japan, at the pharmaceutical company Otsuka. He is currently a full professor in the Department of Molecular Medicine at Laval University, and director of the Functional Genomics Laboratory and SAGE platform at the CHU Research Centre of Quebec. He is an expert in genetic engineering and functional genomics.
Dr. St-Amand’s research program aims to characterize the transcriptomes of several tissues and their regulation through physical exercise, a lipid-rich diet, and steroid hormones, in order to identify, clone and characterize functionally the genes of interest that can be used as therapeutic targets for coronary heart disease, obesity, and cancer. Dr. St-Amand’s laboratory is developing genetic engineering methods and bioinformatics programs, particularly for the analysis of functional genomics results. Dr. St-Amand developed the first SAGE platform in Canada. This powerful strategy makes it possible to compare all transcripts, including new genes, to identify the molecular mechanisms responsible for diseases.
Dr. St-Amand and his team are also studying in vitro cells and knockout mice to characterize the functions of candidate genes. These research projects will identify therapeutic targets to, in turn, develop therapeutic treatments for obesity and cardiovascular disease.
2705, boulevard Laurier
R-4775
Québec, Québec
Canada G1V 4G2
Latest news
- Yoshioka, MayumiEmployeeCHUL+1 418-525-4444, extension 46051mayumi.yoshioka@crchudequebec.ulaval.ca
2705, boulevard Laurier
R-4720
Québec, Québec
Canada G1V 4G2
Measuring Exercise-Induced Secreted Protein Acidic and Rich in Cysteine Expression as a Molecular Tool to Optimize Personalized Medicine
Journal ArticleGenes (Basel), 12 (11), 2021.
Abstract | Links: 
Post-Coronavirus Disease-2019 (COVID-19): Toward a Severe Multi-Level Health Crisis
Journal ArticleMed Sci (Basel), 9 (4), 2021.
Abstract | Links:
Secreted Protein Acidic and Rich in Cysteine as a Molecular Physiological and Pathological Biomarker
Journal ArticleBiomolecules, 11 (11), 2021.
Abstract | Links:
Coronavirus Disease 2019 (COVID-19) Crisis Measures: Health Protective Properties
Journal ArticleMedicines (Basel), 8 (9), 2021.
Abstract | Links:
Coronavirus Disease 2019 (COVID-19) Crisis: Losing Our Immunity When We Need It the Most
Journal ArticleBiology (Basel), 10 (6), 2021.
Abstract | Links:
Trefoil Factor Family Member 2: From a High-Fat-Induced Gene to a Potential Obesity Therapy Target
Journal ArticleMetabolites, 11 (8), 2021.
Abstract | Links:
Obesity as a Neuroendocrine Reprogramming
Journal ArticleMedicina (Kaunas), 57 (1), 2021.
Abstract | Links:
High-Fat Diet-Induced Trefoil Factor Family Member 2 (TFF2) to Counteract the Immune-Mediated Damage in Mice
Journal ArticleAnimals (Basel), 11 (2), 2021.
Abstract | Links:
Obese Animals as Models for Numerous Diseases: Advantages and Applications
Journal ArticleMedicina (Kaunas), 57 (5), 2021.
Abstract | Links:
Secreted Protein Acidic and Rich in Cysteine as A Regeneration Factor: Beyond the Tissue Repair
Journal ArticleLife (Basel), 11 (1), 2021.
Abstract | Links:
Recently finished projects
- Roles of SPARC against muscle atrophy, sarcopenia and age-related metabolic disorders, from 2023-03-01 to 2024-02-29